X0303 4 2010-06-03 0000072444 NABI BIOPHARMACEUTICALS NABI 0001376960 Aryeh Jason 34 SUMMER RD. GREENWICH CT 06831 1 0 0 0 Common Stock 2010-06-03 4 S 0 258 5.81 D 251625 I Indirect The sales reported in this Form 4 were of shares beneficially owned by Jason Aryeh through his relationship with JLV Investments, LP. Consists of (i) 17,000 shares owned directly by Mr. Aryeh; and (ii) the remainder of shares beneficially owned by Jason Aryeh through his relationship with JALAA Equities, LP, JLV Investments, LP, the Jason Aryeh Trust, the Jason Aryeh 2003 Family Trust, and the Jason Aryeh IRA (collectively, the "Aryeh Entities"). Mr. Aryeh disclaims beneficial ownership of all securities held through the Aryeh Entities, except to the extent of any indirect pecuniary interest he may have therein. James E. Dawson, as attorney-in-fact 2010-06-07